D-512, a novel dopamine D2/3receptor agonist, demonstrates greater anti-Parkinsonian efficacy than ropinirole in Parkinsonian rats-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

D-512, a novel dopamine D2/3receptor agonist, demonstrates greater anti-Parkinsonian efficacy than ropinirole in Parkinsonian rats

Published:2017-08-11 Issue:18 Volume:174 Page:3058-3071
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:British Journal of Pharmacology

Author:

Lindenbach David¹,Das Banibrata²,Conti Melissa M¹,Meadows Samantha M¹,Dutta Aloke K²,Bishop Christopher¹^ORCID

Affiliation:

1. Behavioral Neuroscience Program, Department of Psychology; Binghamton University - State University of New York; Binghamton NY USA

2. Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences; Wayne State University; Detroit MI USA

Funder

Center for Development and Behavioral Neuroscience at Binghamton University

Michael J. Fox Foundation for Parkinson's Research

National Institute of Neurological Disorders and Stroke

National Institutes of Neurological Disorders and Stroke

Center for Development and Behavioural Neuroscience at Binghamton University

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.13937/fullpdf

Reference52 articles.

1. The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors;Alexander;Br J Pharmacol,2015a

2. The Concise Guide to PHARMACOLOGY 2015/16: Enzymes;Alexander;Br J Pharmacol,2015b

3. The Concise Guide to PHARMACOLOGY 2015/16: Transporters;Alexander;Br J Pharmacol,2015c

4. Serotonin transporter inhibition attenuates l-DOPA-induced dyskinesia without compromising l-DOPA efficacy in hemi-parkinsonian rats;Bishop;Eur J Neurosci,2012

5. A mouse model of non-motor symptoms in Parkinson's disease: focus on pharmacological interventions targeting affective dysfunctions;Bonito-Oliva;Front Behav Neurosci,2014

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. K₂S₂O₈-mediated direct C–H heteroarylation/hydroxylation of indolin-2-ones with quinoxalin-2(1H)-ones;Organic & Biomolecular Chemistry;2024

2. Treatment of Parkinson's Disease: Current Treatments and Recent Therapeutic Developments;Current Drug Discovery Technologies;2023-09

3. On the Chemical and Biological Characteristics of Multifunctional Compounds for the Treatment of Parkinson’s Disease;Antioxidants;2023-01-17

4. Characterizing the relationship between L-DOPA-induced-dyskinesia and psychosis-like behaviors in a bilateral rat model of Parkinson's disease;Neurobiology of Disease;2023-01

5. Levodopa-Induced Dyskinesia in Parkinson’s Disease: Pathogenesis and Emerging Treatment Strategies;Cells;2022-11-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3